tirzepatide vs semaglutide study New result 🚨 SURMOUNT 5 RCT 📉Total body weight loss: −20.2% with tirzepatide −13.7% with semaglutide 🤢Discontinuations due to gastrointestinal events:… Semaglutide vs tirzepatide vs retatrutide:

Growth in the biosimilars market is mainly driven by factors such as the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness

In post-hoc analyses at 24 weeks, the last time point before placebo participants were eligible for orforglipron as rescue therapy, the change in body weight from ATTAIN-MAINTAIN baseline for patients switching to orforglipron from Wegovy was -0.1 kg vs

This suggests that PUF-8 inhibits proliferative fate through negative regulating GLP-1/Notch signaling or by functioning parallel to it (Racher and Hansen, 2012)

FDA Commissioner Marty Makary said in an X post that the agency will take swift action against companies mass-marketing illegal copycat drugs. Mike Stuart, general counsel for the Department of Health and Human Services, also blasted Hims knockoff pill, saying in a Feb

PFAS, or per- and polyfluoroalkyl substances, are a class of forever chemicals linked to cancer, birth defects, immune suppression, and other health risks

Recently, that ongoing support was put to the test when thousands of patients faced a new hurdle to accessing their GLP-1 medication